Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Do vitamins B12, folate, and B6 deficiency raise homocysteine levels?

Low status of vitamins B12, folate, or B6 impairs homocysteine metabolism and leads to elevated plasma homocysteine.

SupportedJune 19, 202611 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Vitamins B12, folate, and vitamin B6 are required cofactors for homocysteine metabolism, so low status can raise homocysteine.

laying out figure…
All 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that B12 and folate are required for remethylation of homocysteine to methionine and that B6 is required for transsulfuration to cystathionine, so deficits in these cofactors disrupt enzymatic clearance. The mechanism graph frames this as direct impairment of homocysteine metabolic pathways, causing serum homocysteine accumulation when vitamin status is low.

Verified conclusion

Homocysteine is a sulfur-containing amino acid located at the metabolic intersection of the remethylation and transsulfuration pathways. The maintenance of healthy plasma homocysteine concentrations is fundamentally dependent on the availability of specific B-vitamin cofactors.

Mechanistic pathways of homocysteine metabolism

The enzymes governing homocysteine clearance require B-vitamins for their catalytic activity:

  • Remethylation: In the methionine cycle, homocysteine is converted back into methionine by the enzyme methionine synthase (MS). This reaction requires vitamin B12 (as methylcobalamin) as an essential cofactor and 5-methyltetrahydrofolate (the active form of folate) as the primary methyl donor. Deficiencies in either nutrient impair this conversion, leading to cellular and systemic accumulation of homocysteine.
  • Transsulfuration: Homocysteine can also be irreversibly converted into cystathionine and subsequently cysteine. This pathway is regulated by the enzymes cystathionine β-synthase (CBS) and cystathionine γ-lyase (CGL), both of which are strictly dependent on vitamin B6 (as pyridoxal 5'-phosphate) for their function.

Clinical evidence and vitamin status

Low nutritional status of these vitamins is a primary driver of hyperhomocysteinemia, especially in older adults due to age-related changes in absorption or dietary intake.

  • Negative Correlation: In a large cohort study of 1,299 individuals, serum homocysteine showed a strong inverse correlation with both vitamin B12 (r = -0.576) and folate (r = -0.510).
  • Population Prevalence: In studies of elderly males, the prevalence of hyperhomocysteinemia often exceeds 50%, a condition frequently attributed to suboptimal folate and B12 status.
  • Clinical Impacts: Beyond biochemical markers, low B-vitamin status and the resulting elevated homocysteine have been mechanistically linked to hippocampal atrophy and increased risk for cardiovascular and neurodegenerative conditions.

Bottom line

The claim is fully supported by established biochemical pathways and clinical data. Vitamins B12, folate, and B6 are essential enzymatic cofactors; a deficit in any of these nutrients directly elevates homocysteine by disrupting its metabolic clearance.

References

  1. The Role of Hyperhomocysteinemia in Disease — journals.sagepub.com ↗
  2. Polyamine Metabolism and Gene Methylation in Conjunction with One-Carbon Metabolism — mdpi.com ↗
  3. The effect of a subnormal vitamin B-6 status on homocysteine metabolism. — pmc.ncbi.nlm.nih.gov ↗
  4. Vitamin B12, folate, and the methionine remethylation cycle—biochemistry, pathways, and regulation — onlinelibrary.wiley.com ↗
  5. THE ROLE OF FOLATE, VITAMIN B12 AND B6 IN HYPERHOMOCYSTEINEMIA AS THE RISK FACTOR OF CARDIOVASCULAR DISEASE: NARRATIVE REVIEW — jurnal.fk.untad.ac.id ↗
  6. Homocysteine Metabolism in Pregnancy and Developmental Impacts — pmc.ncbi.nlm.nih.gov ↗
  7. Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? — pmc.ncbi.nlm.nih.gov ↗
  8. Hyperhomocysteinemia in Adult Patients: A Treatable Metabolic Condition — pmc.ncbi.nlm.nih.gov ↗
  9. Hyperhomocysteinemia and Disease—Is 10 μmol/L a Suitable New Threshold Limit? — mdpi.com ↗
  10. The relationship between vitamin B12, folate and homocysteine levels in the elderly Turkish population — ejmanager.com ↗
  11. Homocysteine, Cobalamin and Folate Status and their Relations to Neurocognitive and Psychological Markers in Elderly in Northeasten of Iran — ijbms.mums.ac.ir ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→